Expanding Horizons in Atherosclerosis Research

1. Front Matter

   Pages I-XXI

   PDF

2. Pathogenesis and Morphology

   1. Front Matter

      Pages 1-1

      PDF

   2. Pathogenesis of Atherosclerosis: — Current Status

      • M. Daria Haust

      Pages 3-12

   3. The Extracellular Matrix of the Vessel Wall, Its Role and Modification During the Atherosclerotic Process

      • L. Robert

      Pages 13-22

   4. Changing Views of the Morphology of Atherosclerosis

      • G. A. Gresham

      Pages 23-26

   5. Atherosclerosis as a Recurrent Cycle of Inflammation and Repair

      • C. W. M. Adams

      Pages 27-38

   6. Non-Arterial Deposition of Lipids and Lipoproteins: Significance in Relation to Atherogenesis

      • K. W. Walton

      Pages 39-51

   7. On the Role of Lipoprotein Antibody Immune Complexes in Atherogenesis

      • A. N. Klimov

      Pages 52-58

   8. Role of Different Agents Affecting Endothelial Cells in the Process of Atherosclerosis — In Vitro Examinations

      • H. Jellinek, E. Csonka, A. Somogyi, E. Takács

      Pages 59-69

   9. On the Delayed Experimental Pathologic Involvement of Cerebral Arteries in Hypercholesterolemic Monkeys, Rabbits and Spontaneously Hypertensive Rats

      • G. Weber, L. Resi, P. Tanganelli

      Pages 70-75

   10. Enzyme-Acylalcohol-Alcohol Interactions in the Arterial Wall

       • J. Patelski, T. Szwajca, K. Świdzińska

       Pages 76-81

   11. The Effect of Balloon De-Endothelialization on Arterial Enzymes and Metabolic Intermediates in Rabbits

       • T. Zemplenyi, D. W. Crawford, D. F. Tidwell, M. A. Cole

       Pages 82-86

3. Epidemiology, Risk Factors

   1. Front Matter

      Pages 87-87

      PDF

   2. Coronary Heart Disease Epidemiology — Perspectives

      • F. H. Epstein

      Pages 89-95

   3. Obesity and Cardiovascular Disease

      • P. Björntorp

      Pages 96-101

   4. Lipoproteins and Apolipoproteins in the Prediction of Coronary Artery Disease

      • G. Assmann

      Pages 102-113

   5. Prevalence of Hyperlipidaemia in British Compared with North American Men

      • G. R. Thompson, D. Robinson, S. L. Allaway, E. A. Bevan, C. D. Ritchie

      Pages 114-121

   6. Low-Density Lipoprotein: Its Metabolic Determinants and Its Role in Coronary Heart Disease

      • B. Lewis

      Pages 122-125

   7. Plasma Levels of Lipoproteins and Apolipoproteins in Octo- and Nonagenarians

      • P. Avogaro, G. Bittolo-Bon, G. Cazzolato, A. Bottecchia, R. Brugiolo

      Pages 126-131

   8. Cholesteryl Ester Transfer, Lipoproteins, Hypertriglyceridemia, and Atherosclerosis

      • S. Eisenberg

      Pages 132-139

On 29 February 1964, a group of European scientists met in Paris to discuss a subject of common interest, namely atherosclerosis research, with particular reference to international communication and collaboration. After a second meeting on 15 May 1964, they founded the European Atherosclerosis Group which was to com­ prise individuals engaged in the various disciplines of atherosclero­ sis research in Eastern and Western Europe. Since then this group has initiated multidisciplinary discussion and scientific collabora­ tion across Europe, in accordance with the objects and aims written in its statutes: 1. To hold colloquia and symposia dealing with research in the field of atherosclerosis and allied sciences 2. To encourage meetings and exchanges between scientists in the group engaged in the investigation of atherosclerosis 3. To encourage collaborative work between national and interna­ tional centers engaged in atherosclerosis research 4. To encourage the publication of reviews, etc. , on atherosclerosis research which may be considered of value 5. To promote research fellowships, particularly for younger research workers, for studies within the field of atherosclerosis and allied sciences 6. To accept dues, endowments, grants, funds, and bequests to be used for the above purposes The European Atherosclerosis Group has helped to bring together what was separated during the second world war and the postwar period in Europe and to reestablish ties with the leading American teams.

• Lipoprotein
• artery
• atherosclerosis
• birth
• cardiovascular
• communication
• coronary artery disease
• coronary heart disease
• heart
• heart disease
• high-density lipoprotein (HDL)
• myocardial infarction
• platelet
• research
• vascular disease

• Klinisches Institut für Herzinfarktforschung, Medizinische Universitätsklinik Bergheimer, Heidelberg, Germany

  Günter Schlierf

• Innere Abteilung am Diakonissenkrankenhaus Mannheim, Mannheim 1, Germany

  Hubert Mörl

Policies and ethics